Elie Gharib, MD
Interventional Cardiology · South Charleston, WVNPI 1700845559
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $162,804 of the $240,173 with a category attached, or 67.8%. 39 manufacturers reported payments, led by Johnson & Johnson at 30.0% of the total. Among interventional cardiology clinicians in WV with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 737 payments — averaging $325.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$72K
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$37K
- Shockwave Medical, Inc$29K
- Esperion Therapeutics, Inc.$20K
- Amgen$11K
- Amarin Pharma, Inc.$9K
- plus $63K from 33 others
Across 1,518 payments — averaging $873.17 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medtronic$880K
- Biotronik Inc.$393K
- Novartis$21K
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$17K
- Edwards Lifesciences$14K
- Boston Scientific$1K
What the payments were for
- Consulting fees$4,3752%
- Speaking & faculty fees$162,80468%
- Travel & lodging$27,47411%
- Food & beverage$45,52019%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XARELTO$71,698
- LifeVest$33,415
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$27,902
- NEXLIZET$20,211
- NEXLETOL$20,211
- Repatha$10,025
- Vascepa$8,797
- Indigo System$8,108
- TherOx DS2 Console$3,078
- Catheter$3,078
- Downstream Cartridge$3,078
- ENTRESTO$2,859
- Paradise Ultrasound Renal Denervation System$2,691
- OPTIS$1,955
- DyeVert$1,855
- RESOLUTE ONYX$1,606
- Impella$1,210
- RAIN SHEATH$1,125
- FFRct$1,063
- LINQ II$1,010
How this compares
$240,173 in reported general payments places this provider in the 95th percentile of 46 interventional cardiology providers in West Virginia.
See all interventional cardiology providers in West Virginia →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EntrestoSacubitril/Valsartan | 21 | $31,432 |
| EliquisApixaban | 16 | $23,975 |
| Rosuvastatin Calcium | 119 | $1,689 |
| Metoprolol Succinate | 113 | $1,469 |
| Ranolazine ErRanolazine | 16 | $1,093 |
| ClopidogrelClopidogrel Bisulfate | 84 | $794 |
| Atorvastatin Calcium | 82 | $773 |
| Pantoprazole Sodium | 26 | $572 |
| Ezetimibe | 13 | $444 |
| Pravastatin Sodium | 12 | $287 |
| Nitroglycerin | 12 | $233 |
| Amlodipine Besylate | 22 | $219 |
| Potassium Chloride | 25 | $193 |
| Furosemide | 36 | $192 |
| Carvedilol | 25 | $172 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| NovartisEntresto | $3,121 | $31,43221 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 46 interventional cardiology providers in West Virginia.
Other interventional cardiology in South Charleston
- Mitchell RashidSouth Charleston$12K
- Mark BatesCharleston$288K
- Wissam GharibMorgantown$179K
- Anene UkaigweCharleston$168K
- Aravinda NanjundappaBeckley$166K
- Daniel SnavelyHuntington$120K
- Elise AndersonCharleston$38K
- Richard HanCharleston$38K
- Mehrette MaruHuntington$16K
- Kishore ChallaSo Charleston$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.